Feds killed plan to curb Medicare Advantage overbilling after industry opposition

FHS
August 27, 2024
11:09 am

A decade ago, federal officials drafted a plan to discourage Medicare Advantage health insurers from overcharging the government by billions of dollars — only to abruptly back off amid an “uproar” from the industry, newly released court filings show.

Lilly agrees to buy POINT Biopharma for $1.4bn

Lilly offered an acquisition price of $12.5 for each share of POINT. Credit: Michael Vi/Shutterstock.com. Eli Lilly and Company has signed a definitive agreement for

October 4, 2023

Immune dysfunction mechanism discovered in stroke and heart attack patients

Every year, between 250,000 and 300,000 people in Germany suffer from a stroke or heart attack.

April 23, 2024

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

A Democratic congressman on Wednesday blasted a bipartisan set of proposals focused on addiction, arguing that current congressional efforts will barely scratch the surface of

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.